← Xtant Medical Holdings, Inc. XTNT
Market Price
$0.31
Market Cap
$43.48M
P/E Ratio
10.35
Revenue (FY 2025)
↑14.2% YoY
$133.93M
3-Yr CAGR: 32.2%
Net Income
↑130.2% YoY
$4.97M
Net Margin: 3.7%
Free Cash Flow
↑163.5% YoY
$10.16M
FCF Yield: 23.38%
EPS (Diluted)
↑125.0% YoY
$0.03
Basic: $0.04
Return on Equity
Efficiency
9.8%
ROA: 208.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (XTNT)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $90.0M | — | $62.3M | $-19.5M | — | $-1.54 | — | $-14.4M | $-20.2M | — |
| FY 2017 | $82.6M | -8.2% | $50.1M | $-52.4M | -168.9% | $-34.76 | -2,157.1% | $-0.5M | $-2.2M | +89.2% |
| FY 2018 | $71.8M | -13.1% | $43.5M | $-70.1M | -33.7% | $-5.97 | +82.8% | $1.2M | $0.6M | +126.9% |
| FY 2019 | $64.5M | -10.2% | $42.4M | $-8.2M | +88.3% | $-0.63 | +89.4% | $-0.4M | $-1.3M | -319.7% |
| FY 2020 | $53.3M | -17.3% | $34.4M | $-7.0M | +14.6% | $-0.25 | +60.3% | $-0.7M | $-2.3M | -76.2% |
| FY 2021 | $55.3M | +3.6% | $32.5M | $-4.8M | +31.0% | $-0.06 | +76.0% | $0.4M | $-1.7M | +26.4% |
| FY 2022 | $58.0M | +4.9% | $32.1M | $-8.5M | -75.0% | $-0.09 | -50.0% | $-5.3M | $-7.1M | -323.9% |
| FY 2023 | $91.3M | +57.5% | $55.5M | $0.7M | +107.8% | $0.01 | +111.1% | $-9.5M | $-11.0M | -54.4% |
| FY 2024 | $117.3M | +28.4% | $68.2M | $-16.4M | -2,592.3% | $-0.12 | -1,300.0% | $-11.9M | $-16.0M | -45.9% |
| FY 2025 | $133.9M | +14.2% | $84.3M | $5.0M | +130.2% | $0.03 | +125.0% | $12.5M | $10.2M | +163.5% |
Valuation
Market Price
$0.31
Market Cap
$43.48M
Enterprise Value
$40.95M
P/E Ratio
10.35
P/B Ratio
0.85
FCF Yield
23.38%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
62.92%
Operating Margin
5.44%
Net Margin
3.71%
Return on Equity (ROE)
9.76%
Return on Assets (ROA)
208.16%
Asset Turnover
56.06x
Revenue 3-Yr CAGR
32.20%
Financial Health & Liquidity
Current Ratio
0.22
Cash Ratio
1.60
Debt / Equity
0.285
Debt / Assets
6.080
Cash & Equivalents
$17.05M
Total Debt
$14.53M
Book Value / Share
$0.36
Cash Flow Efficiency
Operating Cash Flow
$12.55M
Capital Expenditures (CapEx)
$2.38M
Free Cash Flow
$10.16M
OCF / Revenue
9.37%
FCF / Revenue
7.59%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.03
EPS (Basic)
$0.04
Dividends / Share
N/A
Book Value / Share
$0.36
EPS YoY Growth
125.00%
Balance Sheet (FY 2025)
Total Assets
$2.39M
Total Liabilities
$10.63M
Stockholders' Equity
$50.95M
Current Assets
$2.39M
Current Liabilities
$10.63M